HIV

With the recent approval of new hepatitis C treatments, payers are increasingly concerned with controlling costs in this category through policies that may affect treatment decisions.

Roughly one-third of teen girls' clinicians and almost half of teen boys' clinicians did not recommend HPV vaccination in 2013.

Just 20 or 30 years ago, mention of vitamin supplementation caused many health care professionals to talk about creating "expensive urine." Today, however, vitamin and nutrient supplementation has become an important health care intervention.

Male latex condoms are still the best strategy for reducing the spread of HIV infection.

Temple University researchers' tool requires further investigation, targets virus cells specifically.

Temple University researchers' tool requires further investigation, targets virus cells specifically.

Overall annual diagnosis rate dropped 30% from 2002 to 2011, while a significant increase was found among young men who have sex with men.

More than 2 years after ceasing antiretroviral therapy, HIV is again detectable in "Mississippi baby."

Study finds cancer management guidelines need to be updated to account for patients with HIV.

Researchers continue pursuit of vaccine that will lead to HIV cure.

Researchers find interventions targeting mental health problems and substance abuse can improve treatment outcomes.

Patients with HIV who smoke may be at even greater risk of developing smoking-related cancers.

A study finds that patients co-infected with hepatitis C and HIV who are receiving antiretroviral therapy are 80% more likely to have serious liver disease than those with hepatitis C alone.

A large epidemiologic study in Baltimore and Philadelphia shows that patients with mental illness are 4 times more likely to have HIV infection than the general population. Results of this study reveal a need for routine HIV screening in mental health facilities.

The National Institutes of Health guidelines for prevention of HIV transmission from mother to child were updated on March 28, 2014.

HIV-specialized pharmacies meet the complex needs of HIV-positive patients, helping to provide comprehensive patient care and improve medication adherence to both anti-retroviral therapies and non-HIV medications.

Therapies for hepatitis C, cancer, and orphan conditions are among the specialty drugs expected to receive approval in 2014.

By offering quick and convenient tests for diseases such as influenza, HIV, and hepatitis C, community pharmacies could help improve prevention and treatment.

Fewer opioid treatment centers are offering HIV testing to patients, and are testing fewer patients overall, a recent study suggests.

Patients with co-infection are 80% more likely to have serious liver disease than patients with hepatitis C alone, study finds.

Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.

A molecular geneticist has set out to crowdfund his dream of producing a less time-consuming method of analyzing and sequencing DNA.

Of the 3 to 4 million Americans with chronic HCV infection, only 13% to 18% have received treatment. Understanding the current guidelines in HCV treatment and understanding the current role of direct-acting antiviral agents is an important priority for pharmacists.

In 2013, many new medications and new indications were approved.

A child born infected with HIV in California began treatment hours after birth, and is clear of virus 9 months later.

A significant proportion of teens who were perinatally infected with HIV are at an increased risk for developing atherosclerotic cardiovascular disease, according to a recent study.